Czech tennis player Jakub Mensik went to battle with the Roland Garros crowd on Tuesday and came out on top. Mensik faced French player Alexandre Muller during the first round of the French Open ...

PARIS, France—Jakub Mensik knew facing a French opponent at Roland Garros would be as much of a mental challenge as it was a physical one. So when the crowd made its presence felt—loudly ...

“People have that nurturing instinct,” says Paul G. Wesolowski, president of the Philadelphia Cactus & Succulent Society. “They want to give it love and attention and water, and they ...

“People have that nurturing instinct,” says Paul G. Wesolowski, president of the Philadelphia Cactus & Succulent Society. “They want to give it love and attention and water, and they ...

Alex de Minaur and Jakub Mensik became the latest men’s seeds to fall at the French Open after both players blew two-set leads to lose in the second round on Thursday. Ninth seed De Minaur lost ...

“Remember when tennis was easy? Bunch of random people in top 50. Now this guy is not even top 5, huh?” That was Alexander Bublik’s comment to umpire Mohamed Lahyani in the Madrid Masters ...

Jakub Mensik faced more than just his opponent during his Roland-Garros opener on Tuesday. Taking on Frenchman Alexandre Muller in front of a partisan Paris crowd, the Czech player had to deal ...

From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or ...

City Engineer Allen Wesolowski says the closure represents Phases 2 and 3 of multiple closures for this project and future traffic bulletins will be issued as construction phases are completed.

Multiomic profiling of LRRC15 in triple negative breast cancer (TNBC). A phase 1b study of Plk1 inhibitor onvansertib in combination with paclitaxel in metastatic triple-negative breast cancer (mTNBC) ...

ADELA: A double-blind, placebo-controlled, randomized phase 3 trial of elacestrant (ELA) + everolimus (EVE) versus ELA + placebo (PBO) in ER+/HER2- advanced breast cancer (aBC) patients with ...